Recover, Inc. produces a special kind of targeted therapy drug, which allows Recover to adopt a cost-plus pricing method. Recover has $10,000,000 of assets and investors expect approximately a 10% return on assets. Assume all products produced are sold. Additional data are as follows: sales volume 450,000 units per year, variable costs $16 per unit, fixed costs $1,700,000 per year. Using the cost-plus pricing approach, what should be the sales price per unit? (Round your answer to the nearest cent.)
